The use of high-pressure stent expansion and the combination of effective antiplatelet drugs
have contributed to the extensive use of percutaneous transluminal coronary angioplasty
(PTCA), even in highrisk clinical and angiographic subsets, making this procedure a routine
method of treatment for most coronary lesions. However, interventions on bifurcation
coronary lesions remain complex, especially when the stenosis involves the origins of both
branches. Plaque shift leading to side-branch occlusion can complicate the procedure and …